Raj. HC: Candidate's rejection merely because he suffered disability below the minimum degree illegal  ||  Calcutta HC Allows Bail Application of Former TMC aide Ayan Sil in Recruitment Scam Case  ||  SC Stays Contempt Proceedings in Gujarat High Court Against Judicial Officer  ||  SC Stays Contempt Proceedings in Gujarat High Court Against Judicial Officer  ||  SC Provides Interim Protection to Journalist Mamta Tripathi in UP Police FIR  ||  SC Stays Arrest of YSR Congress Party's Social Media Head for 2 weeks  ||  SC Refuses to Relax GRAP-IV Restriction in National Capital  ||  SC Rejects Plea Challenging SC/ST Reservations in Punjab's Gram Panchayat Posts  ||  SC to States/UTs: File Status Report on Suggestions for Proper Implementation of DV Act  ||  Supreme Court Issues Guidelines for Legal Aid Lawyers, Prosecutors    

Glenmark Settles Patent Litigation over Milnacipran Hydrochloride Tablets - (22 Dec 2015)

Glenmark Pharmaceuticals Inc., USA have entered into a settlement agreement with Forest Laboratories, LLC, Forest Laboratories Holdings, and Royalty Pharma Collection Trust to settle and dismissed outstanding patent litigation related to Glenmark's Abbreviated New Drug Application.

Tags : GLENMARK PHARMACEUTICALS INC   FOREST LABORATORIES   LLC   FOREST LABORATORIES HOLDINGS     ROYALTY PHARMA COLLECTION TRUST  

Share :        

Disclaimer | Copyright 2024 - All Rights Reserved